InteligexFollow

Inteligex
Inteligex2Inteligex@Inteligex2·
25 Nov

Congratulations to Inteligex CMO and CEO, Dr. Chris Ahuja, on being recognized with the Golden Scalpel Award from the Canadian Association of Chairs of Surgical Research!!!

http://cacsr.ca/golden-scalpel-award/

Reply on Twitter 1331680093618511872Retweet on Twitter 1331680093618511872Like on Twitter 13316800936185118723Twitter 1331680093618511872
Inteligex2Inteligex@Inteligex2·
24 Nov

Check out Inteligex's website to learn more about the exciting work being done in Toronto!! #spinalcordinjury #SCI #stemcells #regeneration #innovation #Toronto

https://www.inteligex.ca/

Reply on Twitter 1331340189596311552Retweet on Twitter 1331340189596311552Like on Twitter 1331340189596311552Twitter 1331340189596311552
Inteligex2Inteligex@Inteligex2·
21 Nov

Inteligex President and Founder Dr. Michael Fehlings will be giving an update on Cervical Myelopathy at the World Spinal Column Society tomorrow! #innovation #spine #health

Reply on Twitter 1330296730307457024Retweet on Twitter 1330296730307457024Like on Twitter 13302967303074570242Twitter 1330296730307457024
Inteligex2Inteligex@Inteligex2·
7 Nov

There are distinct neuronal subtypes in the #brain and #spinal_cord. Our #SMaRTcells and #InteliCells have the potential to differentiate into exact neuronal subtypes in the spinal cord and restore the interrupted circuits.

Reply on Twitter 1325081901477081091Retweet on Twitter 13250819014770810911Like on Twitter 13250819014770810912Twitter 1325081901477081091
Inteligex2Inteligex@Inteligex2·
30 Oct

Cell transplantation for #SCI should be patient specific. Various injury characteristics such as cause, level, severity, and age divide individuals with SCI into many subgroups. In our #precision_medicine approach, we have developed different cell types for different patients.

Reply on Twitter 1322236535618633730Retweet on Twitter 13222365356186337301Like on Twitter 13222365356186337301Twitter 1322236535618633730
Inteligex2Inteligex@Inteligex2·
29 Oct

Inteligex uses a personalized medicine approach to process patient data using proprietary AI technology and chooses the best regenerative cell type (InteliCells, SMaRT Cells or WiseCells) to match each individual's condition. @DrFehlings #SCI #spine #stemcells #repair #health

Reply on Twitter 1321906354307649547Retweet on Twitter 13219063543076495473Like on Twitter 13219063543076495474Twitter 1321906354307649547
Retweet on TwitterInteligex Retweeted
pknoepflerPaul Knoepfler@pknoepfler·
28 Oct

Overview of IPS cell prospects for clinical impact including trials such as for cancer, drug screening, and disease modeling. I updated the post by my intern to include more trials
https://ipscell.com/2020/10/overview-of-ips-cell-prospects-for-clinical-impact/ #stemcells #stemcell

Reply on Twitter 1321509224111767552Retweet on Twitter 13215092241117675523Like on Twitter 13215092241117675527Twitter 1321509224111767552
Inteligex2Inteligex@Inteligex2·
26 Oct

On Friday, Inteligex President and Founder Dr. Michael Fehlings gave a presentation for the Tator-Turnbull Symposium. A highlight from his talk is below discussing some of our exciting technologies! #stemcells #regeneration #spinalcordinjury #SCI #hope

Reply on Twitter 1320863263089975302Retweet on Twitter 13208632630899753021Like on Twitter 13208632630899753022Twitter 1320863263089975302
load more...